Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)
China · Delayed Price · Currency is CNY 16.89
+0.06 (0.36%)
Nov 10, 2026, 9:55 AM CST
SHA:605033 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 222.04 | 338.24 | 267.86 | 481.17 | 318.25 | 254.39 |
Short-Term Investments | - | - | - | - | 1.5 | - |
Trading Asset Securities | 307.13 | 425.87 | 388.47 | - | 79.93 | 148 |
Cash & Short-Term Investments | 529.17 | 764.11 | 656.33 | 481.17 | 399.68 | 402.39 |
Cash Growth | -17.74% | 16.42% | 36.40% | 20.39% | -0.67% | 101.79% |
Accounts Receivable | 145.49 | 59.3 | 77.16 | 148.68 | 189.08 | 92.49 |
Other Receivables | 2.17 | 10.78 | 12.29 | 10.52 | 35.69 | 2.04 |
Receivables | 147.66 | 70.08 | 89.45 | 159.2 | 224.77 | 94.53 |
Inventory | 196.24 | 233.39 | 264.71 | 353.7 | 457.29 | 559.56 |
Prepaid Expenses | - | - | - | - | 14.09 | - |
Other Current Assets | 152.2 | 89.55 | 86.22 | 77.73 | 92.58 | 136.3 |
Total Current Assets | 1,025 | 1,157 | 1,097 | 1,072 | 1,188 | 1,193 |
Property, Plant & Equipment | 769.57 | 764.15 | 613.67 | 457.07 | 185.84 | 115.72 |
Other Intangible Assets | 114.14 | 117.06 | 118.48 | 83.23 | 12.27 | 7.7 |
Long-Term Deferred Tax Assets | 8.18 | 12.43 | 15.7 | 16.43 | 12.42 | 4.26 |
Long-Term Deferred Charges | 0.57 | 0.53 | 0.54 | 0.42 | 0.76 | 0.97 |
Other Long-Term Assets | 10.59 | 16.83 | 16.93 | 63.05 | 160.79 | 141.94 |
Total Assets | 1,928 | 2,068 | 1,862 | 1,692 | 1,560 | 1,463 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 163.03 | 322.17 | 305.84 | 171.77 | 102.68 | 130.52 |
Accrued Expenses | 32.84 | 56.68 | 47.77 | 50.06 | 75.87 | 44.23 |
Short-Term Debt | 1 | 11.01 | - | 1 | - | 27.05 |
Current Portion of Long-Term Debt | - | 4.14 | 1.08 | - | - | - |
Current Income Taxes Payable | 2.76 | 0.18 | 0.44 | 1.77 | 2.85 | 5.55 |
Current Unearned Revenue | 227.42 | 302.84 | 252.07 | 227.97 | 151.4 | 219.24 |
Other Current Liabilities | 32.34 | 8.24 | 9.06 | 8.34 | 36.93 | 10.48 |
Total Current Liabilities | 459.4 | 705.26 | 616.26 | 460.91 | 369.72 | 437.07 |
Long-Term Debt | 147 | 135.51 | 72 | - | - | - |
Long-Term Unearned Revenue | 3.06 | 3.62 | 3.25 | 1.2 | 0.78 | 0.87 |
Long-Term Deferred Tax Liabilities | 4.58 | 4.68 | 4.61 | 4.78 | 5.63 | 5.42 |
Other Long-Term Liabilities | 122.83 | 66.01 | 41.26 | 110.96 | 98.02 | 53.08 |
Total Liabilities | 736.86 | 915.09 | 737.37 | 577.84 | 474.14 | 496.43 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 135.2 | 135.2 | 135.2 | 135.2 | 137.79 | 135.2 |
Additional Paid-In Capital | 459.37 | 459.37 | 459.37 | 459.37 | 482.34 | 459.37 |
Retained Earnings | 596.89 | 558.48 | 530.09 | 519.6 | 491.78 | 372.38 |
Treasury Stock | - | - | - | - | -25.57 | - |
Shareholders' Equity | 1,191 | 1,153 | 1,125 | 1,114 | 1,086 | 966.95 |
Total Liabilities & Equity | 1,928 | 2,068 | 1,862 | 1,692 | 1,560 | 1,463 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 148 | 150.66 | 73.08 | 1 | - | 27.05 |
Net Cash (Debt) | 381.17 | 613.45 | 583.25 | 480.17 | 399.68 | 375.34 |
Net Cash Growth | -22.73% | 5.18% | 21.47% | 20.14% | 6.49% | 88.22% |
Net Cash Per Share | 2.78 | 4.54 | 4.27 | 3.59 | 2.95 | 3.40 |
Filing Date Shares Outstanding | 135.2 | 135.2 | 135.2 | 135.2 | 137.79 | 135.2 |
Total Common Shares Outstanding | 135.2 | 135.2 | 135.2 | 135.2 | 137.79 | 135.2 |
Working Capital | 565.87 | 451.87 | 480.45 | 610.89 | 818.69 | 755.71 |
Book Value Per Share | 8.81 | 8.53 | 8.32 | 8.24 | 7.88 | 7.15 |
Tangible Book Value | 1,077 | 1,036 | 1,006 | 1,031 | 1,074 | 959.25 |
Tangible Book Value Per Share | 7.97 | 7.66 | 7.44 | 7.63 | 7.79 | 7.10 |
Buildings | - | 375.37 | 155.85 | 70.81 | 68.09 | 62.58 |
Machinery | - | 258.77 | 201.85 | 151.47 | 146.71 | 101.66 |
Construction In Progress | - | 264.59 | 364.64 | 325.93 | 44.37 | 11.93 |